(Q37932437)

25 August 2017

title

Dual biological effects of the cytokines interleukin-10 and interferon-γ. (English)

1 reference

25 August 2017

0 references

4

Ilona Kryczek

1 reference

25 August 2017

Cailin Moira Wilke

1

1 reference

25 August 2017

Shuang Wei

2

1 reference

25 August 2017

Lin Wang

3

1 reference

25 August 2017

John Kao

5

1 reference

25 August 2017

Weiping Zou

6

1 reference

25 August 2017

publication date

15 September 2011

1 reference

Cancer Immunology, Immunotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

60

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1529-1541

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1104-5

25 August 2017

exact match

0 references

cites work

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-10: the master regulator of immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10: new perspectives on an old cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Altered immune responses in interleukin 10 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Immune privilege in sites of chronic infection: Leishmania and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

HLA-G and IL-10 expression in human cancer--different stories with the same message

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 and the immune response against cancer: a counterpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Natural killer cells and the MHC class I pathway of peptide presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 provides direct trophic support to neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Virus interference. II. Some properties of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Regulation of MHC class II genes: lessons from a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Autocrine secretion of interferon gamma negatively regulates homing of immature B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

T(H)17 cells in tumour immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Functional role of type I and type II interferons in antiviral defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

The roles of IFN gamma in protection against tumor development and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Regulation of interleukin 12 p40 expression through an NF-kappa B half-site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Creating immune privilege: active local suppression that benefits friends, but protects foes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Regulation of cytokine receptor signaling by SOCS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-γ links ultraviolet radiation to melanomagenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1104-5

10.1007/S00262-011-1104-5

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference